Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-035529
Filing Date
2023-06-08
Accepted
2023-06-08 17:14:08
Documents
1
Period of Report
2023-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4362
  Complete submission text file 0001209191-23-035529.txt   5749
Mailing Address PORTOLA PHARMACEUTICALS, INC. 270 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Curnutte John T (Reporting) CIK: 0001574589 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39303 | Film No.: 231002919

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Issuer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations